7.02
0.00
(0.00%)
As of April 8 at 3:48:24 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.12 | -0.09 | -0.07 | 1.03 |
| Low Estimate | -0.19 | -0.14 | -0.4 | 0.91 |
| High Estimate | -0.07 | -0.01 | 0.22 | 1.11 |
| Year Ago EPS | 0.56 | -0.27 | 0 | -0.07 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 8.18M | 9.35M | 47.86M | 82.13M |
| Low Estimate | 7.57M | 8.41M | 36.27M | 66.51M |
| High Estimate | 8.96M | 10.6M | 62.32M | 120.31M |
| Year Ago Sales | 25.38M | 7.26M | 47.54M | 47.86M |
| Sales Growth (year/est) | -67.76% | 28.80% | 0.67% | 71.63% |
Earnings History
| Currency in CAD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.06 | 0.03 | -0.11 | -0.19 |
| EPS Actual | 0.56 | -0.27 | -0.29 | -0.09 |
| Difference | 0.62 | -0.31 | -0.18 | 0.1 |
| Surprise % | 1,013.70% | -1,010.00% | -167.63% | 53.40% |
EPS Trend
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.09 | -0.07 | 1.03 |
| 7 Days Ago | -0.12 | -0.09 | -0.08 | 1.04 |
| 30 Days Ago | -0.16 | -0.11 | -0.23 | 0.78 |
| 60 Days Ago | -0.16 | -0.11 | -0.23 | 0.78 |
| 90 Days Ago | -0.15 | -0.09 | 0.14 | 1.53 |
EPS Revisions
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | 1 |
| Up Last 30 Days | 2 | 2 | 2 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 2 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FRX.TO | -121.84% | 68.80% | 0.00% | 1,491.55% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/17/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/22/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 8/14/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 5/15/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/15/2024 |
Related Tickers
MBX.TO Microbix Biosystems Inc.
0.3650
-1.35%
MDNA.TO Medicenna Therapeutics Corp.
0.8800
+3.53%
COV.V Covalon Technologies Ltd.
2.3300
+3.10%
APS.TO Aptose Biosciences Inc.
3.0000
-11.76%
ONC.TO Oncolytics Biotech Inc.
0.6900
-1.43%
EWTX Edgewise Therapeutics, Inc.
10.83
-5.79%
AVXL Anavex Life Sciences Corp.
7.68
+1.05%
NVAX Novavax, Inc.
6.20
-1.74%
MRNA Moderna, Inc.
24.31
-1.34%